Orthofix Medical Inc

OFIX.US
Healthcare · Medical Devices
12.26
+0.36 (+3.03%)
USD · NASDAQ

Company Information

Company Name
Orthofix Medical Inc
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US68752M1080
CIK: 0000884624
CUSIP: 68752M108
Currency: USD
Full Time Employees: 1,605
Phone: 214 937 2000
Fiscal Year End: December
IPO Date: Apr 24, 1992
Description:

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and 7D FLASH Navigation System, a navigation platform for spinal and cranial procedures. The Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market, including deformity correction, limb lengthening, complex fracture management, and limb preservation. This segment also designs, develops, and markets external and internal fixation limb reconstruction products that are coupled with enabling digital technologies to support the entire patient care continuum. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, healthcare providers, ambulatory surgery centers, and out-patient hospitals. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Address:

3451 Plano Parkway, Lewisville, TX, United States, 75056

People

Directors & Officers

Name Title Year Born
Mr. Massimo Calafiore President, CEO & Director 1972
Ms. Julie B. Andrews Chief Financial Officer 1971
Ms. Aviva McPherron President of Global Operations & Quality 1977
Mr. J. Andres Cedron Chief Legal Officer & Corporate Secretary 1981
Mr. Patrick Fisher President of Global Biologics & Limb Reconstruction 1974
Mr. Geoffrey C. Gillespie Chief Accounting Officer NA
Ms. Julie D. Dewey Chief Investor Relations & Communications Officer 1961
Ms. Jill Mason Chief Compliance & Risk Officer NA
Ms. Stephanie Walsh Chief Human Resources Officer NA
Dr. Beau Standish P.Eng., Ph.D. Chief Enabling Technologies Officer 1980

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 16, 2026 Jorge Andres Cedron N/A Sale 3.74K $12.82 $47.99K
Mar 17, 2026 Lucas Vitale N/A Sale 4.27K $11.92 $50.89K
Feb 25, 2026 Engine Capital Management, Lp N/A Purchase 13.06K $12.96 $169.27K
Feb 24, 2026 Engine Capital Management, Lp N/A Purchase 124.80K $12.55 $1.57M
Jan 16, 2026 Julie Andrews N/A Sale 4.87K $14.38 $70.07K
Jan 12, 2026 Massimo Calafiore N/A Sale 9.80K $15.21 $149.01K
Jan 09, 2026 Massimo Calafiore N/A Sale 9.60K $15.82 $151.87K
Jul 02, 2025 Engine Capital Management, Lp N/A Purchase 1.25K $11.11 $13.89K
Jun 18, 2025 Aviva Mcpherron N/A Sale 3.73K $10.51 $39.18K
Jun 04, 2025 Alan Lee Bazaar N/A Purchase 2.25K $10.92 $24.57K
May 09, 2025 Massimo Calafiore N/A Purchase 10.00K $12.54 $125.40K
May 07, 2025 Engine Capital Management, Lp N/A Purchase 100.00K $12.31 $1.23M

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Engine Capital Management LP 4.39M Mar 31, 2026 10.86% $6.08 3.24%
Juniper Investment Co, LLC 3.98M Mar 31, 2026 9.84% $14.56 13.29%
Rubric Capital Management LP 3.72M Mar 31, 2026 9.21% $0.45 0.00%
Paradigm Capital Management, Inc. 3.30M Mar 31, 2026 8.18% $1.45 0.00%
BlackRock Inc 3.21M Mar 31, 2026 7.94% $0.00 2.16%
Armistice Capital, LLC 2.70M Mar 31, 2026 6.68% $0.55 1.96%
Vanguard Group Inc 2.30M Dec 31, 2025 5.70% $0.00 0.98%
Vanguard Capital Management, LLC 1.66M Mar 31, 2026 4.10% $0.00 0.00%
Millennium Management LLC 1.07M Mar 31, 2026 2.64% $0.01 -25.97%
Geode Capital Management, LLC 938.89K Mar 31, 2026 2.32% $0.00 -0.88%
State Street Corp 907.43K Mar 31, 2026 2.24% $0.00 5.80%
Dimensional Fund Advisors, Inc. 841.52K Mar 31, 2026 2.08% $0.00 -11.33%
Acadian Asset Management LLC 559.84K Mar 31, 2026 1.39% $0.01 182.85%
Philosophy Capital Management LLC 558.90K Mar 31, 2026 1.38% $0.39 -44.95%
Vanguard Portfolio Management, LLC 396.57K Mar 31, 2026 0.98% $0.00 0.00%
Jacobs Levy Equity Management, Inc. 379.12K Mar 31, 2026 0.94% $0.02 162.35%
Northern Trust Corp 337.34K Mar 31, 2026 0.83% $0.00 5.87%
Charles Schwab Investment Management Inc 325.74K Mar 31, 2026 0.81% $0.00 -2.42%
The Goldman Sachs Group Inc 324.43K Mar 31, 2026 0.80% $0.00 53.45%
Tudor Investment Corp Et AL 262.97K Mar 31, 2026 0.65% $0.01 29.80%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 1.21M 3.01% ▲ 0.00% Jun 30, 2026
2 iShares Russell 2000 ETF 1.04M 2.56% ▲ 0.60% Jun 30, 2026
3 Vanguard Institutional Extnd Mkt Idx Tr 473.62K 1.17% ▲ 6.18% Jun 30, 2026
4 Paradigm Micro-Cap 400.00K 0.99% ▲ 0.00% Jun 30, 2026
5 Fidelity Small Cap Index 383.76K 0.95% ▲ 0.82% Apr 30, 2026
6 iShares Russell 2000 Value ETF 346.69K 0.86% ▼ 0.69% Jun 30, 2026
7 State St Russell Sm/Mid Cp® Indx SL Cl I 262.30K 0.65% ▲ 0.00% Jun 30, 2026
8 Russell 2000 Equity Index Fund B 248.40K 0.61% ▼ 0.16% Jun 30, 2026
9 Russell 2000 Index Non-Lendable Fund 248.40K 0.61% ▼ 0.16% Jun 30, 2026
10 Vanguard Russell 2000 ETF 232.40K 0.57% ▲ 15.43% Jun 30, 2026

Financial Highlights

Market Cap: $481.02M
EBITDA: $17.00M
PEG Ratio: $48.83
Book Value: $10.78
Earnings/Share: $-1.50
Profit Margin: -7.27%
Operating Margin: -6.75%
ROA (TTM): -3.25%
ROE (TTM): -13.43%
Revenue (TTM): $825.37M
Revenue/Share (TTM): $20.68
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 1.60%

Valuation Metrics

Enterprise Value: $596.72M
Trailing P/E: 0.00
Forward P/E: 500.00

Shares Statistics

Shares Outstanding: 40.42M
Shares Float: 40.10M
% Insiders: 219.40%
% Institutions: 9,193.00%
Short % Float: 7.02%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$822.31M
Cost of Goods Sold
adjust
$-270.61M
Gross Profit
subtotal
$551.71M
SG&A
adjust
$-554.33M
R&D
adjust
$-57.11M
Other Operating Expense
adjust
$-8.74M
Operating Income
subtotal
$-68.47M
Other / Non-Operating Items
adjust
$-23.72M
Net Income
subtotal
$-92.19M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about OFIX.US!